Nature Communications · 4 Sept 2026 · Journal Article · Open access

HDAC inhibition via suberoylanilide hydroxamic acid ameliorates doxorubicin-induced cardiotoxicity.

Eksi, Finke + more

Open access

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

IFN-γ drives long-term bone marrow niche dysfunction following doxorubicin-based chemotherapy.
Blood · 3 Sept 2026 · Journal Article
IFN-γ-driven inflammation causes long-term bone marrow niche dysfunction after doxorubicin chemotherapy, impairing hematopoietic and skeletal health.
- Open access
- 1 cites
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42008378
Open in JClub
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial.
Circulation · 1 Sept 2026 · Letter
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42439484
Open in JClub
Immune Checkpoint Inhibitor Myocarditis and Myotoxicity.
Circulation · 1 Sept 2026 · Review
ICI-associated myocarditis is part of a systemic cardiomuscular syndrome with variable severity, affecting up to 50% of cases and requiring tailored management strategies.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42709038
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read